BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9589471)

  • 1. Expression of KAI1 in paraffin-embedded normal, hyperplastic and neoplastic prostate and prostate carcinoma cell lines.
    Ward JM; Konishi N; Ohshima M; Lamb PW; Jorcyk CL; Barrett JC
    Pathol Int; 1998 Feb; 48(2):87-92. PubMed ID: 9589471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the KAI1 protein in benign prostatic hyperplasia and prostate cancer.
    Ueda T; Ichikawa T; Tamaru J; Mikata A; Akakura K; Akimoto S; Imai T; Yoshie O; Shiraishi T; Yatani R; Ito H; Shimazaki J
    Am J Pathol; 1996 Nov; 149(5):1435-40. PubMed ID: 8909232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KAI1/CD82 protein expression in primary prostate cancer and in BPH associated with cancer.
    Lijovic M; Somers G; Frauman AG
    Cancer Detect Prev; 2002; 26(1):69-77. PubMed ID: 12088206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
    De Marzo AM; Meeker AK; Epstein JI; Coffey DS
    Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features.
    Gabal SM; Habib FM; Helmy DO; Ibrahim MF
    J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of the KAI1 metastasis suppressor gene during the progression of human prostatic cancer infrequently involves gene mutation or allelic loss.
    Dong JT; Suzuki H; Pin SS; Bova GS; Schalken JA; Isaacs WB; Barrett JC; Isaacs JT
    Cancer Res; 1996 Oct; 56(19):4387-90. PubMed ID: 8813131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the rat homologue of KAI1 and its expression in Dunning rat prostate cancers.
    Suzuki H; Dong JT; Gao AC; Barrett JC; Isaacs JT
    Prostate; 1998 Dec; 37(4):253-60. PubMed ID: 9831222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the prostate cancer metastasis suppressor gene KAI1 in primary prostate cancers: a biphasic relationship with tumour grade.
    Bouras T; Frauman AG
    J Pathol; 1999 Aug; 188(4):382-8. PubMed ID: 10440748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate.
    Ware JL; Maygarden SJ; Koontz WW; Strom SC
    Hum Pathol; 1991 Mar; 22(3):254-8. PubMed ID: 1672281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of retinoblastoma and p53 tumor suppressor genes in prostatic intraepithelial neoplasia: comparison with prostatic adenocarcinoma and benign prostate.
    Tamboli P; Amin MB; Xu HJ; Linden MD
    Mod Pathol; 1998 Mar; 11(3):247-52. PubMed ID: 9521470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
    Wu GJ; Wu MW; Wang SW; Liu Z; Qu P; Peng Q; Yang H; Varma VA; Sun QC; Petros JA; Lim SD; Amin MB
    Gene; 2001 Nov; 279(1):17-31. PubMed ID: 11722842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues.
    Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M
    J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of a human cell adhesion molecule, MUC18, in prostate cancer cell lines and tissues.
    Wu GJ; Varma VA; Wu MW; Wang SW; Qu P; Yang H; Petros JA; Lim SD; Amin MB
    Prostate; 2001 Sep; 48(4):305-15. PubMed ID: 11536311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate specific membrane antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 184 cases.
    Bostwick DG; Pacelli A; Blute M; Roche P; Murphy GP
    Cancer; 1998 Jun; 82(11):2256-61. PubMed ID: 9610707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pattern of CD10 expression in selected pathologic entities of the prostate gland.
    Tawfic S; Niehans GA; Manivel JC
    Hum Pathol; 2003 May; 34(5):450-6. PubMed ID: 12792918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-1 and galectin-3 expression in human prostate tissue and prostate cancer.
    Ellerhorst J; Troncoso P; Xu XC; Lee J; Lotan R
    Urol Res; 1999 Oct; 27(5):362-7. PubMed ID: 10550525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic regulation of the KAI1 metastasis suppressor gene in human prostate cancer cell lines.
    Sekita N; Suzuki H; Ichikawa T; Kito H; Akakura K; Igarashi T; Nakayama T; Watanabe M; Shiraishi T; Toyota M; Yoshie O; Ito H
    Jpn J Cancer Res; 2001 Sep; 92(9):947-51. PubMed ID: 11572762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.
    Geradts J; Maynard R; Birrer MJ; Hendricks D; Abbondanzo SL; Fong KM; Barrett JC; Lombardi DP
    Am J Pathol; 1999 Jun; 154(6):1665-71. PubMed ID: 10362791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KAI1/CD82 gene expression in benign prostatic hyperplasia and late-stage prostate cancer in Chinese.
    Hu WL; Li YQ; He HX; Li QR; Tian Y; Lai RQ; Mei H
    Asian J Androl; 2000 Sep; 2(3):221-4. PubMed ID: 11225981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases.
    Hull D; Ma J; Singh H; Hossain D; Qian J; Bostwick DG
    BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.